EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting cullin neddylation for cancer and fibrotic diseases

Zhang-Xu He, Wei-Guang Yang, Dan Zengyangzong, Ge Gao, Qian Zhang, Hong-Min Liu, Wen Zhao, Li-Ying Ma

Theranostics · 2023 · 13 (14) · 5017-5056

DOI: 10.7150/thno.78876 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2023. Verfasst von Zhang-Xu He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Henan University of Chinese Medicine, 450046, Zhengzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Lymphoma. Die Arbeit wurde bisher 51-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein neddylation is a post-translational modification, and its best recognized substrates are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs). Given that most neddylation pathway proteins are overactivated in different cancers and fibrotic diseases, targeting neddylation becomes an emerging approach for the treatment of these diseases. To date, numerous neddylation inhibitors have been developed, of which MLN4924 has entered phase I/II/III clinical trials for cancer treatment, such as acute myeloid leukemia, melanoma, lymphoma and solid tumors. Here, we systematically describe the structures and biological functions of the critical enzymes in neddylation, highlight the medicinal chemistry advances in the development of neddylation inhibitors and propose the perspectives concerning targeting neddylation for cancer and fibrotic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsLymphomaHumansCullin ProteinsNEDD8 ProteinProtein Processing, Post-Translational

Stichwörter der Autor:innen

CancerCullin neddylationFibrotic diseasesInhibitors

Substanzen

Cullin ProteinsNEDD8 Protein

Autor:innen und Institutionen

  • Pharmacy College, Henan University of Chinese Medicine, 450046, Zhengzhou, China.
  • State Key Laboratory of Esophageal Cancer Prevention and Treatment; Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzho…
  • Children's hospital affiliated of Zhengzhou university; Henan children's hospital; Zhengzhou children's hospital, Henan Zhengzhou 450000, China.
  • China Meheco Topfond Pharmaceutical Co., Zhumadian 463000, China.
  • Key Laboratory of Cardio-cerebrovascular Drug, Henan Province, Zhumadian 463000, China.

Zitieren

APA

He, Z. X., Yang, W. G., Zengyangzong, D., Gao, G., Zhang, Q., Liu, H. M., Zhao, W., & Ma, L. Y. (2023). Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics, 13(14), 5017-5056. https://doi.org/10.7150/thno.78876

Vancouver

He ZX, Yang WG, Zengyangzong D, Gao G, Zhang Q, Liu HM, et al. Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023;13(14):5017-5056. doi:10.7150/thno.78876

BibTeX
@article{He2023,
  author = {He, Zhang-Xu and Yang, Wei-Guang and Zengyangzong, Dan and Gao, Ge and Zhang, Qian and Liu, Hong-Min and Zhao, Wen and Ma, Li-Ying},
  title = {Targeting cullin neddylation for cancer and fibrotic diseases},
  journal = {Theranostics},
  year = {2023},
  volume = {13},
  number = {14},
  pages = {5017--5056},
  doi = {10.7150/thno.78876}
}
Kostenlos starten →